Literature DB >> 26017546

Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.

Els F van den Ban1, Patrick C Souverein, Herman van Engeland, Hanna Swaab, Toine C G Egberts, Eibert R Heerdink.   

Abstract

PURPOSE: Differences in incidence and prevalence of ADHD medication use between ethnic groups have been reported. Goal of this study was to determine whether there are also differences in usage patterns of ADHD medication among native Dutch children and adolescents and those with a Moroccan, Turkish and Surinam cultural background in the Netherlands between 1999 and 2010.
METHODS: In a cohort of ADHD patients <19 years (N = 817) incident use and discontinuation of ADHD medication were measured for ethnicity and adjusted for age, gender and socio-economic status.
RESULTS: A significant higher proportion of ADHD-diagnosed patients from Moroccan (32 %) and Turkish (42 %) cultural background never used ADHD medication compared to Dutch natives (21 %). One-fifth of native Dutch and Turkish patients already used ADHD medication before the ADHD diagnosis date. Discontinuation of ADHD medication within 5 years was significantly higher in Moroccan [HR 2.4 (95 % CI 1.8-3.1)] and Turkish [HR 1.7 (95 % CI 1.1-2.6)] patients. A sensitivity analysis with a zip code-matched comparison between Dutch natives and non-natives showed similar results, suggesting this effect is probably not explained by socio-economic status (SES).
CONCLUSION: Differences are found in prescribing and use of ADHD medication between patients with a different cultural background. Native Dutch and Turkish patients start more frequently with ADHD medication before the ADHD diagnose date, which can be an indication of differences in either referral patterns and/or access to care. A higher percentage of patients with a Moroccan and Turkish cultural background never start using ADHD medication at all and discontinuation rate is higher compared to Dutch natives and Surinamese.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26017546     DOI: 10.1007/s00127-015-1068-4

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  65 in total

1.  Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

Authors:  Julie Magno Zito; Daniel J Safer; Ilene H Zuckerman; James F Gardner; Karen Soeken
Journal:  Psychiatr Serv       Date:  2005-02       Impact factor: 3.084

2.  Medicaid expenditures on psychotropic medications for children in the child welfare system.

Authors:  Ramesh Raghavan; Derek S Brown; Hope Thompson; Susan L Ettner; Lisa M Clements; Whitney Key
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

3.  Stimulant medication use in children: a 12-year perspective.

Authors:  Samuel H Zuvekas; Benedetto Vitiello
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

4.  Understanding ethnic differences in mental health service use for adolescents' internalizing problems: the role of emotional problem identification.

Authors:  Esmée E Verhulp; Gonneke W J M Stevens; Rens van de Schoot; Wilma A M Vollebergh
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-02-12       Impact factor: 4.785

Review 5.  Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

Authors:  Steve S Lee; Kathryn L Humphreys; Kate Flory; Rebecca Liu; Kerrie Glass
Journal:  Clin Psychol Rev       Date:  2011-01-20

6.  Trends in the prescribing of psychotropic medications to preschoolers.

Authors:  J M Zito; D J Safer; S dosReis; J F Gardner; M Boles; F Lynch
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

7.  Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

Authors:  Emily Simonoff; Eric Taylor; Gillian Baird; Sarah Bernard; Oliver Chadwick; Holan Liang; Susannah Whitwell; Kirsten Riemer; Kishan Sharma; Santvana Pandey Sharma; Nicky Wood; Joanna Kelly; Ania Golaszewski; Juliet Kennedy; Lydia Rodney; Nicole West; Rebecca Walwyn; Fatima Jichi
Journal:  J Child Psychol Psychiatry       Date:  2012-06-07       Impact factor: 8.982

8.  Race/ethnicity and insurance status as factors associated with ADHD treatment patterns.

Authors:  Jack Stevens; Jeffrey S Harman; Kelly J Kelleher
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-02       Impact factor: 2.576

9.  Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment.

Authors:  Esther Sobanski; Daniel Brüggemann; Barbara Alm; Sebastian Kern; Alexandra Philipsen; Hannah Schmalzried; Bernd Hesslinger; H Waschkowski; Marcella Rietschel
Journal:  Eur Psychiatry       Date:  2007-11-19       Impact factor: 5.361

10.  Attention-deficit/hyperactivity disorder: increased costs for patients and their families.

Authors:  Andrine R Swensen; Howard G Birnbaum; Kristina Secnik; Maryna Marynchenko; Paul Greenberg; Ami Claxton
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

View more
  6 in total

Review 1.  Problematic Peer Functioning in Girls with ADHD: A Systematic Literature Review.

Authors:  Francien M Kok; Yvonne Groen; Anselm B M Fuermaier; Oliver Tucha
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

2.  Dispensing of psychotropic medication among 400,000 immigrants in The Netherlands.

Authors:  Fabian Termorshuizen; Jean-Paul Selten; Eibert R Heerdink
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-06-14       Impact factor: 4.328

3.  Barriers and predictors of medication use for childhood ADHD: findings from a UK population-representative cohort.

Authors:  A E Russell; T Ford; G Russell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

4.  Maternal Sociodemographic Factors Are Associated with Methylphenidate Initiation in Children in the Netherlands: A Population-Based Study.

Authors:  K Cheung; H El Marroun; B Dierckx; L E Visser; B H Stricker
Journal:  Child Psychiatry Hum Dev       Date:  2021-04

Review 5.  Autism Spectrum and Other Neurodevelopmental Disorders in Children of Immigrants: A Brief Review of Current Evidence and Implications for Clinical Practice.

Authors:  Heiko Schmengler; David Cohen; Sylvie Tordjman; Maria Melchior
Journal:  Front Psychiatry       Date:  2021-03-18       Impact factor: 4.157

6.  Time of onset and/or diagnosis of ADHD in European children: a systematic review.

Authors:  Ilaria Rocco; Barbara Corso; Maurizio Bonati; Nadia Minicuci
Journal:  BMC Psychiatry       Date:  2021-11-16       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.